CompletedPhase 1NCT05208814
A Study to Evaluate the Pharmacokinetics and Safety of TPN171H Tablets in Patients with Renal Insufficiency and Healthy Subjects
Studying Heritable pulmonary arterial hypertension
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Vigonvita Life Sciences
- Principal Investigator
- Jia MiaoWest China Hospital
- Intervention
- TPN171H single dose(drug)
- Enrollment
- 16 enrolled
- Eligibility
- 18-70 years · All sexes
- Timeline
- 2022 – 2022
Study locations (2)
- West China Hospital, Chengdu, Sichuan, China
- Chengdu Xinhua Hospital, Chengdu, Sichuan, China
Collaborators
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05208814 on ClinicalTrials.govOther trials for Heritable pulmonary arterial hypertension
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07498244Collagen Fingerprinting for Stratification of Pulmonary Hypertension (PH) PatientsMedical University of Graz
- RECRUITINGNANCT07079592A Deep-Learning-Enabled Electrocardiogram for Detecting Pulmonary HypertensionNational Defense Medical Center, Taiwan
- RECRUITINGPHASE4NCT07147114Clinical Trial to Evaluate the Efficacy and Safety in Concomitant Administration of Macitentan and Dapagliflozin in Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction (HFmrEF and HFpEF) and Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH)Gachon University Gil Medical Center
- RECRUITINGPHASE2NCT07073820A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489Pfizer
- RECRUITINGNCT07537517Evaluation of the BMPR2-Activin Signaling Pathway in Group II Pulmonary Hypertension.Hospital General Universitario Gregorio Marañon
- RECRUITINGNANCT07120789Validation of a Patient Knowledge Questionnaire for Pulmonary HypertensionUniversity of Sao Paulo General Hospital
- RECRUITINGNANCT07576894Right Ventricular Response to Exercise Among Patients With Chronic Obstructive Pulmonary DiseaseUniversity of Colorado, Denver
- RECRUITINGNCT07087613Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECGEko Devices, Inc.
See all trials for Heritable pulmonary arterial hypertension →